Neuroinflammation and immune-brain interactions

Clinical MedicineUpdated Oct 5, 2026Version v1

Evidence

Public papers linked to this topic and used as evidence for gaps, timelines, and knowledge views.

358 papers

Showing 217-228 of total 358 evidence records.

Open a paper to inspect abstract, source links, and topic context.

2026PubMedSupporting evidence

Stem cell and stem cell-derived extracellular vesicle therapy for traumatic brain injury: mechanisms, engineering and translation.

Bi S; Gao D; Zhu K; Liu S; Chen L; Jiang W; Liang G

2026PubMedSupporting evidence

Extracellular vesicles carrying the tenascin-C protein participate in glucose metabolism in neurodegenerative injury via inhibiting the AKT/GLUT1 pathway.

Liu X; Chen L; Zhu X; Wu Q; Bu C; Zheng F; Yu G; Hu H; Guo Z; Zhou J; Wu S; Li H; Shao W

Jan 1, 2026Chemico-biological interactions

2026PubMedDirectly related

Neuroimmune mechanisms in PTSD: inflammatory heterogeneity, circuit dysfunction, and biomarker-based subtypes.

Majumdar S; Samaiya PK; Ahmed S; Krishnamurthy S; Prajapati SK

Jan 1, 2026Molecular biology reports

2026PubMedSupporting evidence

Hypothalamic neurovascular and extracellular matrix remodeling: Cellular niche orchestration of immune-metabolic adaptation to nutritional stress.

Mendes NF

Jan 1, 2026Reviews in endocrine & metabolic disorders

2026PubMedDirectly related

Terpenes as Potential Multi-Target Modulators of Chronic Stress-Induced Neuroendocrine-Immune Dysregulation.

Kočović DM; Momčilović S; Svetozarević T

Jan 1, 2026International journal of molecular sciences

2026PubMedSupporting evidence

Quercetin Alleviates Neuroinflammation in Chronic Insomnia by Modulating the RAGE/NF-κB Signaling Pathway: Insights from Network Pharmacology and In Vitro Validation.

Liu G; Cai N; Wang H; Liu M; Yan W; Zhao Y; Cui M; Kong X; Sun H; Zhao P

Jan 1, 2026Biomedicines

2026PubMedSupporting evidence

Intranasal bFGF‑Els alleviate doxorubicin‑induced cognitive deficits in mice by modulating the PI3K/AKT pathway and suppressing oxidative stress, neuroinflammation, and apoptosis.

Zhang M; He WY; Ma WC; Yu SF

Jan 1, 2026Brain, behavior, and immunity

2026PubMedSupporting evidence

Polysaccharides targeting organelle network dysfunction in Alzheimer's disease: A review.

Yu X; Gao P; Yao Q; Yuan F; Jing W

Jan 1, 2026International journal of biological macromolecules

2026PubMedSupporting evidence

Clinical immunology lessons from failed α-Synuclein and Tau immunotherapies: A roadmap for combination strategies in Alzheimer's disease.

Abdelaziz AM; Eltyar FS

Jan 1, 2026Clinical immunology (Orlando, Fla.)

2026PubMedDirectly related

Csf1r-mediated depletion of myeloid cells prevents dopaminergic neuron loss during chronic colitis.

Kutscherauer RK; Andert M; Stolzer I; Neumaier EE; Dedden M; Kielkowski P; Xiang W; Grotemeyer A; Prinz M; Masuda T; Knobeloch KP; Rothhammer V; Zundler S; Schlachetzki JCM; Winkler J; Günther C; Süß P

Jan 1, 2026Journal of neuroinflammation

2026PubMedSupporting evidence

A multi-omics framework integrating gut microbiota, blood metabolites, and immune cells to elucidate the pathogenesis of Alzheimer's disease.

Wang B; Yan W; Zhang Y

Jan 1, 2026Frontiers in immunology

2026PubMedSupporting evidence

Montelukast Ameliorates Antimony-Induced Neurotoxicity Accompanied by Alterations in Oxidative Stress, Neuroinflammation, and Mitochondrial Function.

Atul; Gupta S; Tyagi S; Panwar C; Panwar V; Singh P

Jan 1, 2026Biological trace element research